Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety, Tolerability, and Population Pharmacokinetics of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients.
Arrieta AC, Neely M, Day JC, Rheingold SR, Sue PK, Muller WJ, Danziger-Isakov LA, Chu J, Yildirim I, McComsey GA, Frangoul HA, Chen TK, Statler VA, Steinbach WJ, Yin DE, Hamed K, Jones ME, Lademacher C, Desai A, Micklus K, Phillips DL, Kovanda LL, Walsh TJ. Arrieta AC, et al. Among authors: lademacher c. Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0029021. doi: 10.1128/AAC.00290-21. Epub 2021 Jul 16. Antimicrob Agents Chemother. 2021. PMID: 34031051 Free PMC article.
Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole.
Kovanda LL, Marty FM, Maertens J, Desai AV, Lademacher C, Engelhardt M, Lu Q, Hope WW. Kovanda LL, et al. Among authors: lademacher c. Antimicrob Agents Chemother. 2017 May 24;61(6):e00101-17. doi: 10.1128/AAC.00101-17. Print 2017 Jun. Antimicrob Agents Chemother. 2017. PMID: 28289034 Free PMC article. Clinical Trial.
Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials.
Andes DR, Ghannoum MA, Mukherjee PK, Kovanda LL, Lu Q, Jones ME, Santerre Henriksen A, Lademacher C, Hope WW. Andes DR, et al. Among authors: lademacher c. Antimicrob Agents Chemother. 2018 Dec 21;63(1):e01634-18. doi: 10.1128/AAC.01634-18. Print 2019 Jan. Antimicrob Agents Chemother. 2018. PMID: 30373791 Free PMC article. Clinical Trial.
No Dose Adjustment for Isavuconazole Based on Age or Sex.
Desai AV, Han D, Kowalski DL, Lademacher C, Pearlman H, Yamazaki T. Desai AV, et al. Among authors: lademacher c. Antimicrob Agents Chemother. 2019 May 24;63(6):e02629-18. doi: 10.1128/AAC.02629-18. Print 2019 Jun. Antimicrob Agents Chemother. 2019. PMID: 30962330 Free PMC article.
A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis.
Benjamin DK Jr, Kaufman DA, Hope WW, Smith PB, Arrieta A, Manzoni P, Kovanda LL, Lademacher C, Isaacson B, Jednachowski D, Wu C, Kaibara A, Walsh TJ. Benjamin DK Jr, et al. Among authors: lademacher c. Pediatr Infect Dis J. 2018 Oct;37(10):992-998. doi: 10.1097/INF.0000000000001996. Pediatr Infect Dis J. 2018. PMID: 29596222 Free PMC article. Clinical Trial.
Pharmacokinetic Effects of Isavuconazole Coadministration With the Cytochrome P450 Enzyme Substrates Bupropion, Repaglinide, Caffeine, Dextromethorphan, and Methadone in Healthy Subjects.
Yamazaki T, Desai A, Goldwater R, Han D, Howieson C, Akhtar S, Kowalski D, Lademacher C, Pearlman H, Rammelsberg D, Townsend R. Yamazaki T, et al. Among authors: lademacher c. Clin Pharmacol Drug Dev. 2017 Jan;6(1):54-65. doi: 10.1002/cpdd.281. Epub 2016 Jul 15. Clin Pharmacol Drug Dev. 2017. PMID: 27273149 Free PMC article. Clinical Trial.
Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial.
Kullberg BJ, Viscoli C, Pappas PG, Vazquez J, Ostrosky-Zeichner L, Rotstein C, Sobel JD, Herbrecht R, Rahav G, Jaruratanasirikul S, Chetchotisakd P, Van Wijngaerden E, De Waele J, Lademacher C, Engelhardt M, Kovanda L, Croos-Dabrera R, Fredericks C, Thompson GR. Kullberg BJ, et al. Among authors: lademacher c. Clin Infect Dis. 2019 May 30;68(12):1981-1989. doi: 10.1093/cid/ciy827. Clin Infect Dis. 2019. PMID: 30289478 Clinical Trial.
35 results